COMP <GO>
TDY vs TMO // EV/EBITDA & P/E VALUATION
Teledyne Technologies Incorporated (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: TDY 9
— TMO 4
▲ EV/EBITDA & P/E VALUATION LEADER: TDY
LAST: $658.23 (-2.84%) • MKT CAP: $31.19B
valuation
26.3x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDY VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TDY | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.50% | 9.30% | -1.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 26.3x | 30.4x | -4.10 | TDY | /valuation <GO> |
| Free Cash Flow Yield | 3.44% | 2.40% | +1.04 | TDY | /fcf-yield <GO> |
| Operating Margin | 18.80% | 17.40% | +1.40 | TDY | /operating-margins <GO> |
| Net Profit Margin | 14.60% | 15.10% | -0.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 7.90% | 3.90% | +4.00 | TDY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.32 | 4.50 | +0.82 | TDY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | TDY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.6 | 62.9 | +5.70 | TDY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.94 | +0.21 | TDY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.5x | 36.3x | -3.80 | TDY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $31.19B | $262.22B | -$231.03B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TDY REV | TMO REV | TDY GROSS % | TMO GROSS % | TDY FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.12B | $44.56B | 42.8% | — | $1.07B | $6.29B |
| FY 2024 | $5.67B | $42.88B | 42.9% | — | $1.11B | $7.27B |
| FY 2023 | $5.64B | $42.86B | — | — | $582.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDY // BETA 1.15
TMO // BETA 0.94